Case studies
Innovative Technology to Maximize the Potential of Enzyme Therapies
Market strategy and clinical prioritization for a platform with potential across multiple lysosomal disorders.
Challenge
Researchers had developed a therapeutic platform with the potential to address limitations of current treatments for lysosomal disorders by improving the distribution and efficacy of enzyme therapies. Arvor’s challenge was to assess unmet medical needs, prioritize the indications with the greatest potential, and analyze the competitive landscape to guide development toward real market opportunities.
Solution
A comprehensive analysis of the main lysosomal disorders was carried out to identify those with the strongest clinical and commercial fit for the platform. The work included evaluating existing treatments, unmet medical needs, key stakeholders, and innovation trends. In addition, interviews with clinical specialists were conducted to validate the identified opportunities from a real-world clinical perspective. Based on these insights, a prioritization and development strategy was defined to maximize the technology’s value and transfer potential.
Result
The project identified the most attractive opportunities for the platform within the lysosomal disease field and clarified the key factors that will influence its future development. As a result, a prioritization strategy supported by market evidence and clinical validation was established, strengthening the technology’s transferability and value creation potential.
“As a result, a prioritization strategy supported by market evidence and clinical validation was established, strengthening the technology’s transferability and value creation potential”
Success case studies in the sector Biotech
Case studies of Market analysis